Rebamipide is a quinolinone derivative introduced as a novel antiulcer agent. It acts
as a local gastric mucosa prostaglandin inducer and is reported to be effective in both the healing and prevention of recurrence of gastric ulcer.
REBAMIPIDE is used in stomach ulcer.
ChEBI: 2-[[(4-chlorophenyl)-oxomethyl]amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid is a secondary carboxamide.
